Clinical trials
Phase 4 Lupus Nephritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 7 |
| Unknown status | 5 |
| Withdrawn | 4 |
| Terminated | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 3 |
| Mansoura University | 2 |
| Tuen Mun Hospital | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Ahmed Yehia Ismail | 1 |
| Al-Azhar University | 1 |
| Astellas Pharma Korea, Inc. | 1 |
| Aurinia Pharmaceuticals Inc. | 1 |
| Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 1 |
| Brigham and Women's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Nephritis | 29 |
| Lupus Erythematosus, Systemic | 7 |
| Glomerulonephritis | 3 |
| Nephritis | 3 |
| Proteinuria | 3 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Hematuria | 1 |
| Kidney Diseases | 1 |
| Renal Insufficiency, Chronic | 1 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.